InMed Pharmaceuticals Inc (MWG) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.12M	820.19K	-	-
Cost of goods sold	716.96K	635.99K	-	-
Cost of revenue	716.96K	635.99K	-	-
Research and development expenses	581.61K	630.64K	1.02M	805.74K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.53M	1.62M	1.74M	2.36M
Operating expense	2.17M	2.30M	2.82M	3.21M
Total operating expenses	2.88M	2.94M	2.82M	3.21M
Operating income	-1.76M	-2.12M	-2.82M	-3.21M
Other non operating income	-	-	-	-
EBT including unusual items	-1.73M	-2.03M	-2.79M	-4.84M
EBT excluding unusual items	-1.73M	-2.03M	-2.79M	-3.19M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-1.73M	-2.03M	-2.97M	-5.84M
Net profit margin	-154.17%	-247.29%	-	-
Earnings per share	-	-	-	-
Interest and investment income	93.76K	74.38K	47.77K	29.06K
Interest expense	-	-	-	-10.70K
Net interest expenses	93.76K	74.38K	47.77K	18.36K
Depreciation and amortization charges	53.20K	53.20K	51.71K	48.36K
EBITDA	-1.71M	-2.07M	-2.77M	-3.16M
Gain or loss from assets sale	-	-	-	7.14K

Finance